The consequence of the mutation A>G in the OPMR1 gene is an additional net charge with loss of a putative glucosylation site in the area of the ligand-receptor interaction and this feature may have consequences for the sensitivity to opioids of pain patients, although the phenotype of the pain seems to be essential.
